Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting News provided by Share this article Share this article SAN DIEGO, April 27, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced three data presentations to be delivered at the upcoming American Society of Gene and Cell Therapy (ASGCT) 24th Annual Meeting, being held virtually May 11-14, 2021. Poseida ...
Source: prnewswire.com